Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.925 USD | +1.37% | -10.16% | -33.59% |
Mar. 27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
Mar. 27 | Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.59% | 176M | |
-1.97% | 103B | |
+0.49% | 95.71B | |
+1.69% | 22.02B | |
-16.98% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.99% | 15.52B | |
+3.69% | 13.86B | |
+35.10% | 12.04B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Bluebird bio : Secures $75 Million Private Placement